v3.25.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Principles of Consolidation

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the unaudited financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The interim results for the period ended June 30, 2025 are not necessarily indicative of the results that may be expected through December 31, 2025. All intercompany accounts and transactions are eliminated upon consolidation. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s annual report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission on April 15, 2025.

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of the consolidated financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statement.

 

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Cash and cash equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had a cash and cash equivalents balance of $17,556 and $103,774 as of June 30, 2025 and December 31, 2024, respectively.

 

Investments Held in Trust Account

 

The Company’s portfolio of investments held in the Trust Account is comprised of investments only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair value of investments held in the Trust Account is determined using available market information. As of June 30, 2025 and December 31, 2024, the Trust Account had balance of $8,315,560 and $75,794,241, respectively. The interest and dividend income earned from the Trust Account totalled $88,405 and $185,727 for three and six months ended June 30, 2025, respectively, which were fully reinvested into the Trust Account as earned and unrealized gain on investments and therefore presented as an adjustment to the operating activities in the Consolidated Statements of Cash Flows.

 

Offering Costs

 

Offering costs consist of legal and other costs (including underwriting discounts and commissions) incurred through the balance sheet date that are directly related to the IPO and that were charged to shareholders’ equity upon the completion of the IPO on July 14, 2023.

 

Interest Expenses

 

Interest expense in 2024 and 2025 are primarily from the amortization of the debt discount in connection with the promissory note issued by the Company to related party. See Note 4 - Related Parties for more information.

 

Amortization of Debt Discount

 

The Company’s promissory note issued with related party is recorded net of debt discount which comprised issuance costs, and the discount initially recognized for the fair value of the shares transferred. The portion of the debt issuance costs allocated to the promissory note, is being amortized over the terms, which is upon consummation of the Business Combination. The amortization of debt issuance costs and discount is included in interest expense within the accompanying consolidated statements of operations.

 

Payable to Target Company

 

The balance of payable to target company represents expenses incurred and paid by Qianzhi on behalf of the Company. These expenses are unrelated to business combination transaction costs and primarily include Nasdaq fees, audit review fees, and other costs related to the Company’s operations. As of June 30, 2025 and December 31, 2024, the Company reported outstanding balances of $242,316 and $75,000, respectively.

 

FPA Liability

 

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480, “Distinguishing Liabilities from Equity” and ASC 815-40, “Derivatives and Hedging—Contracts in Entity’s Own Equity” (“ASC 815-40”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

 

The forward purchase option in the FPA of the Company meets the definition of an obligation to repurchase shares by transferring assets arrangement under ASC 480-10, therefore, the forward purchase option is required to be classified as a liability at fair value. Subsequently, changes in fair value are reported in earnings in statements of operations.

 

Financing Expenses

 

The Company accounts for its share-based compensation in accordance with ASC 718, Compensation – Stock Compensation. Share-based compensation cost is measured at the grant date, based on the estimated fair value of the award, and is recognized as expense over the requisite service period. The 50,000 Commitment Shares in the FPA is an equity consideration transferred to a non-employee for financing services and therefore falls within the scope of ASC 718-10. The fair value of the financing expenses shall be measured based on the observable market price.

 

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2025 and December 31, 2024. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position.

 

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s consolidated financial statements.

 

Net Income (Loss) per Ordinary Share

 

The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. As of June 30, 2025 and 2024, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.

 

The net income (loss) per share presented in the statements of operations is based on the following:

 

   2025   2024   2025   2024 
   For Three Months
Ended June 30,
   For Six Months
Ended June 30,
 
   2025   2024   2025   2024 
Net income (loss)  $750,303   $816,754   $(1,289,691)  $1,603,116 
Interest earned on investment held in Trust Account   (88,405)   (941,850)   (185,727)   (1,865,342)
Net income (loss) including accretion of equity into redemption value  $661,898   $(125,096)  $(1,475,418)  $(262,226)

 

Particulars  Shares   Shares   Shares   Shares   Shares   Shares   Shares   Shares 
   For Three Months
Ended
June 30, 2025
   For Six Months
Ended
June 30, 2025
   For Three Months
Ended
June 30, 2024
   For Six Months
Ended
June 30, 2024
 
   Redeemable   Non-Redeemable   Redeemable   Non-Redeemable   Redeemable   Non-Redeemable   Redeemable   Non-Redeemable 
Particulars  Shares   Shares   Shares   Shares   Shares   Shares   Shares   Shares 
Basic and diluted net income (loss) per share:                                        
Weighted-average shares outstanding   759,249    2,266,500    1,238,013    2,266,500    6,900,000    2,266,500    6,900,000    2,266,500 
Ownership percentage   25%   75%   35%   65%   75%   25%   75%   25%
Numerators:                                        
Allocation of net income (loss) including accretion of temporary equity   166,090    495,808    (521,210)   (954,208)   (94,165)   (30,931)   (197,388)   (64,838)
Interest earned on investment held in trust account   88,405    -    185,727    -    941,850    -    1,865,342    - 
Allocation of net income (loss)   254,495    495,808    (335,483)   (954,208)   847,685    (30,931)   1,667,954    (64,838)
Denominators:                                        
Weighted-average shares outstanding   759,249    2,266,500    1,238,013    2,266,500    6,900,000    2,266,500    6,900,000    2,266,500 
Basic and diluted net income (loss) per share  $0.34   $0.22   $(0.27)  $(0.42)  $0.12   $(0.01)  $0.24   $(0.03)

 

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

 

Fair Value of Financial Instruments

 

The forward purchase option in the FPA of the Company meets the definition of an obligation to repurchase shares by transferring assets arrangement under ASC 480 and therefore qualify as financial instruments under ASC 820 “Fair Value Measurement.” The Company’s FPA liability is considered to be Level 3 financial instruments measured at fair value on a recurring basis. See Note 7 for details. The fair value of the Company’s other assets and liabilities, which qualify as financial instruments under ASC 820, approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.

 

Ordinary Shares Subject to Possible Redemption

 

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.

 

At June 30, 2025, the ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:

 

Public offering proceeds  $60,000,000 
Less:     
Proceeds allocated to Public Rights   (3,272,724)
Allocation of offering costs related to redeemable shares   (2,925,140)
Plus:     
Accretion of carrying value to redemption value   6,797,864 
Ordinary shares subject to possible redemption   60,600,000 
      
Over-allotment     
Plus:     
Over-allotment proceeds   9,000,000 
Less:     
Proceeds allocated to Public Rights   (490,909)
Allocation of offering costs related to redeemable shares   (212,727)
Plus:     
Accretion of carrying value to redemption value   793,636 
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)   1,729,358 
Ordinary shares subject to possible redemption, December 31, 2023  $71,419,358 
Plus:     
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)   3,684,883 
Subsequent measurement of ordinary shares subject to possible redemption (extension deposit)   690,000 
Ordinary shares subject to possible redemption, December 31, 2024  $75,794,241 
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)   97,321 
Subsequent measurement of ordinary shares subject to possible redemption (redemption)   (66,519,453)
Ordinary shares subject to possible redemption, March 31, 2025  $9,372,109 
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)   88,405 
Subsequent measurement of ordinary shares subject to possible redemption (redemption)   (1,144,954)
Ordinary shares subject to possible redemption, June 30, 2025  $8,315,560 

 

 

Recent Accounting Standards

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.